Portfolio moves
Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.
Dec 31, 2025 → Mar 31, 2026
Expand a category to see the positions behind it, ranked by weight.
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| DEFINIUM THERAPEUTICS INC | 0 | 316,882 | 316,882 | 1.80% | $5.99M |
| INDIVIOR PHARMACEUTICALS INC | 0 | 179,821 | 179,821 | 1.65% | $5.48M |
| BIOAGE LABS INC | 0 | 210,974 | 210,974 | 1.11% | $3.69M |
| FULCRUM THERAPEUTICS INC | 0 | 367,717 | 367,717 | 0.85% | $2.82M |
| LB PHARMACEUTICALS INC | 0 | 89,202 | 89,202 | 0.66% | $2.20M |
| ALTO NEUROSCIENCE INC | 0 | 73,288 | 73,288 | 0.50% | $1.65M |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| MIND MEDICINE MINDMED INC | 346,070 | 0 | -346,070 | 0.00% | -$4.63M |
| INDIVIOR PLC | 120,856 | 0 | -120,856 | 0.00% | -$4.34M |
| AVADEL PHARMACEUTICALS PLC | 199,457 | 0 | -199,457 | 0.00% | -$4.30M |
| VENTYX BIOSCIENCES INC | 249,901 | 0 | -249,901 | 0.00% | -$2.26M |
| LENZ THERAPEUTICS INC | 138,668 | 0 | -138,668 | 0.00% | -$2.22M |
| EVOLUS INC | 333,163 | 0 | -333,163 | 0.00% | -$2.22M |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| State Street Navigator Securities Lending Portfolio II | 15,401,052 | 24,663,467 | 9,262,415 | 7.42% | $9.26M |
| ENLIVEN THERAPEUTICS INC | 161,593 | 192,297 | 30,704 | 2.27% | $5.05M |
| CORCEPT THERAPEUTICS INC | 50,221 | 174,971 | 124,750 | 2.12% | $5.31M |
| TERNS PHARMACEUTICALS INC | 96,040 | 126,197 | 30,157 | 2.00% | $2.77M |
| PERRIGO CO PLC | 316,890 | 601,785 | 284,895 | 1.95% | $2.05M |
| AXSOME THERAPEUTICS INC | 28,704 | 37,013 | 8,309 | 1.88% | $1.01M |
| INNOVIVA INC | 207,776 | 263,314 | 55,538 | 1.85% | $1.98M |
| MERCK & CO | 43,888 | 50,800 | 6,912 | 1.84% | $1.49M |
| PFIZER INC | 166,188 | 216,247 | 50,059 | 1.83% | $1.93M |
| ROYALTY PHARMA PLC | 111,980 | 126,441 | 14,461 | 1.83% | $1.74M |
| ELANCO ANIMAL HEALTH INC | 201,143 | 251,749 | 50,606 | 1.81% | $1.47M |
| JAZZ PHARMA PLC | 25,971 | 31,838 | 5,867 | 1.81% | $1.60M |
| ESPERION THERAPEUTICS INC NEW | 1,118,628 | 2,194,800 | 1,076,172 | 1.81% | $1.87M |
| EDGEWISE THERAPEUTICS INC | 180,470 | 190,497 | 10,027 | 1.81% | $1.52M |
| MBX BIOSCIENCES INC | 148,659 | 200,744 | 52,085 | 1.80% | $1.30M |
| BRISTOL-MYERS SQUIBB CO | 83,663 | 98,425 | 14,762 | 1.80% | $1.46M |
| ANI PHARMACEUTICALS INC | 52,229 | 77,382 | 25,153 | 1.79% | $1.83M |
| JOHNSON&JOHNSON | 20,743 | 24,295 | 3,552 | 1.79% | $1.65M |
| TARSUS PHARMACEUTICALS INC | 52,685 | 84,481 | 31,796 | 1.78% | $1.61M |
| TREVI THERAPEUTICS INC | 302,354 | 494,432 | 192,078 | 1.78% | $2.11M |
| PACIRA BIOSCIENCES INC | 170,149 | 258,586 | 88,437 | 1.76% | $1.44M |
| ZOETIS INC CL A | 36,287 | 49,282 | 12,995 | 1.75% | $1.26M |
| CRINETICS PHARMACEUTICALS INC | 89,146 | 159,642 | 70,496 | 1.74% | $1.65M |
| NEKTAR THERAPEUTICS | 74,200 | 80,506 | 6,306 | 1.74% | $2.66M |
| LIQUIDIA TECHNOLOGIES INC | 131,100 | 153,099 | 21,999 | 1.74% | $1.26M |
| AMNEAL PHARM INC | 350,889 | 464,477 | 113,588 | 1.74% | $1.35M |
| HARMONY BIOSCIENCES HOLDINGS INC | 109,100 | 205,054 | 95,954 | 1.73% | $1.66M |
| SUPERNUS PHARMACEUTICALS INC | 92,815 | 110,926 | 18,111 | 1.73% | $1.12M |
| VIATRIS INC | 369,340 | 422,585 | 53,245 | 1.72% | $1.11M |
| XERIS BIOPHARMA HOLDINGS INC | 617,340 | 975,649 | 358,309 | 1.70% | $812.65K |
| HARROW INC | 85,345 | 159,813 | 74,468 | 1.70% | $1.45M |
| ORGANON & CO | 596,705 | 922,423 | 325,718 | 1.66% | $1.25M |
| NUVATION BIO INC | 546,473 | 1,286,168 | 739,695 | 1.66% | $621.26K |
| AMYLYX PHARMACEUTICALS INC | 323,836 | 395,413 | 71,577 | 1.65% | $1.58M |
| COLLEGIUM PHARMACEUTICAL INC | 87,686 | 165,736 | 78,050 | 1.65% | $1.42M |
| LILLY ELI and CO | 4,312 | 5,904 | 1,592 | 1.63% | $796.30K |
| PRESTIGE CONSUMER HEALTHCARE INC | 69,823 | 91,089 | 21,266 | 1.62% | $1.09M |
| LIGAND PHARMACEUTICALS | 23,281 | 26,684 | 3,403 | 1.60% | $925.72K |
| OCULAR THERAPEUTIX INC | 278,023 | 621,423 | 343,400 | 1.58% | $1.89M |
| OMEROS CORP | 224,036 | 494,846 | 270,810 | 1.57% | $1.38M |
| EYEPOINT PHARMACEUTICALS INC | 256,241 | 395,677 | 139,436 | 1.53% | $418.75K |
| ALUMIS INC | 75,453 | 224,127 | 148,674 | 1.49% | $4.20M |
| AMPHASTAR PHARMACEUTICALS INC | 140,767 | 227,681 | 86,914 | 1.34% | $690.53K |
| PHATHOM PHARMACEUTICALS INC | 253,875 | 398,901 | 145,026 | 1.33% | $220.00K |
| THERAVANCE BIOPHARMA INC | 104,548 | 268,815 | 164,267 | 1.31% | $2.41M |
| ARVINAS INC | 323,442 | 362,073 | 38,631 | 1.16% | $1.95K |
| CORMEDIX INC | 325,517 | 554,307 | 228,790 | 1.13% | -$22.02K |
| MAZE THERAPEUTICS INC | 96,097 | 117,041 | 20,944 | 1.05% | -$487.62K |
| SEPTERNA INC | 77,297 | 128,633 | 51,336 | 0.93% | $936.01K |
| WAVE LIFE SCIENCES LTD | 211,782 | 419,283 | 207,501 | 0.91% | -$560.49K |
| ZEVRA THERAPEUTICS INC | 291,732 | 324,871 | 33,139 | 0.91% | $413.88K |
| AQUESTIVE THERAPEUTICS INC | 465,934 | 600,305 | 134,371 | 0.75% | -$518.67K |
| Security | Shares Dec 2025 | Shares Mar 2026 | Δ shares | End % | Δ value |
|---|---|---|---|---|---|
| PHIBRO ANIMAL HEALTH CORP CL A | 99,663 | 99,625 | -38 | 1.66% | $1.79M |
| RAPPORT THERAPEUTICS INC | 142,934 | 134,504 | -8,430 | 1.27% | -$127.99K |
No positions in this category.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.